Circuit Clinical
Venture Round in 2022
Circuit Clinical is an integrated research organization that facilitates participation in clinical research for patients and healthcare providers. Founded in 2015, it emerged from the experiences of a physician who recognized the importance of trust in the clinical research process. Circuit Clinical focuses on enhancing physician and participant engagement, leveraging HIPAA and FDA-compliant Electronic Medical Record (EMR) reviews to identify motivated participants. The organization provides a suite of technology products designed to improve the clinical research experience for both participants and physicians. By connecting a network of over one million patients with community physicians and research sponsors, Circuit Clinical aims to improve site quality and patient safety, making clinical research more accessible and navigable for all involved.
AllStripes
Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of treatments for rare diseases. The company has created a platform that produces regulatory-ready evidence to support rare disease research and drug development. This platform operates as a two-sided network where patients with rare diseases and advocacy groups contribute valuable information, while life science companies utilize this data to identify new drug candidates. Additionally, AllStripes offers a patient application that allows individuals to engage in treatment research online and leverage their own medical data, fostering a collaborative environment aimed at advancing medical research for rare conditions.
SHYFT Analytics
Acquisition in 2018
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.
Syapse, Inc. is a company that develops a precision medicine software platform aimed at improving cancer care through the integration and analysis of diverse clinical, molecular, treatment, and outcomes data. By leveraging real-world evidence, Syapse enables healthcare organizations to collaborate effectively, providing comprehensive patient insights that inform clinical decisions. Its primary offering, the Syapse Learning Health Network, serves as a global data-sharing network that supports oncologists and life sciences collaborators with actionable insights derived from real-world data. Founded in 2008 and headquartered in San Francisco, California, with an additional office in Radnor, Pennsylvania, Syapse works to enhance precision medicine programs and drive impactful outcomes for cancer patients. The company has also established a strategic partnership with Pfizer to further its mission in the field of precision oncology.
Mytrus
Acquisition in 2017
Mytrus, Inc. is a clinical technology company based in Davis, California, specializing in patient-centered electronic informed consent and data collection tools. Founded in 2009, Mytrus develops solutions that facilitate remote electronic consent and virtual data collection for clinical trials, enabling patients to participate conveniently from their homes. The company offers a range of technologies, including electronic patient-reported outcomes (ePRO), electronic data capture (EDC), and biosample consent tracking, along with site training and e-learning applications. These tools enhance accessibility and compliance, while also reducing costs associated with clinical trials. Mytrus holds a patent for conducting virtual clinical trials in the United States, underscoring its innovative approach to advancing clinical research. As of April 2017, Mytrus operates as a subsidiary of Medidata Solutions, Inc.
SHYFT Analytics
Series B in 2017
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.
Chita, Inc. is a subsidiary of Medidata Solutions, Inc., based in San Mateo, California, specializing in enterprise content management for the life sciences sector. The company offers a unified platform that facilitates the creation, storage, viewing, collaboration, and editing of both regulated and non-regulated content within a single application. Its system incorporates role-based access, flexible workflows, file access control, and comprehensive metadata management, allowing users to effectively manage their content requirements. Additionally, Chita's platform includes features such as document migration, electronic signatures, compound document assembly, and audit trails, tailored to enhance collaboration and maintain content integrity in modern digital workplaces.
SHYFT Analytics
Series B in 2016
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.
Intelemage
Acquisition in 2016
Intelemage, LLC specializes in providing PACS administration, network management, software development, and application security solutions tailored for the radiology and telecommunications sectors. Based in Cincinnati, Ohio, the company operates The InteleGRID image sharing network, which facilitates the acquisition, management, and distribution of medical images for various stakeholders, including pharmaceutical and medical device companies, hospitals, healthcare facilities, and professional sports organizations. Intelemage supports medical image and clinical data collaboration for core laboratories, contract research organizations, and physicians, and is recognized for its reliability by numerous prestigious institutions and professionals in the healthcare industry. As of April 2016, Intelemage operates as a subsidiary of Medidata Solutions, Inc.
Clinical Force
Acquisition in 2011
Clinical Force is a privately-held company specializing in clinical trials management systems (CTMS) for the life sciences sector. With offices in the US and Europe, it serves small to medium-sized life science organizations, aiming to enhance clinical processes through user-friendly and cost-effective software solutions. The company leverages its extensive experience with contract research organizations (CROs) and sponsors to offer a comprehensive platform that facilitates collaboration between sponsors and their partners. Clinical Force operates on four continents, demonstrating its global reach and commitment to improving clinical trial management.
Fast Track
Acquisition in 2008
Fast Track: a completely new and comprehensive approach to the way clinical trials are managed. The company is assembling a creative and energetic staff of technical and medical professionals, an experienced management team, industry-specific advisory boards, and an active investor constituency - all aggressively focused on achieving their vision: to revolutionize the management of clinical trials.
Medidata Solutions
Venture Round in 2002
Medidata Solutions, Inc. is a global provider of cloud-based solutions for the life sciences industry. It offers a unified platform, Medidata Clinical Cloud, which encompasses data capture and management, trial planning, and analytics to facilitate the development and commercialization of new therapies. The company also provides centralized statistical monitoring, patient engagement tools, and professional services such as implementation, consulting, and training. Medidata's clients include pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as academic research centers and contract research organizations. The company, founded in 1999, is headquartered in New York and operates as a subsidiary of Dassault Systèmes Americas Corp.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.